• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性尿酸通过Toll样受体4介导的途径增加人原代肾近端小管上皮细胞中NALP3炎性小体和白细胞介素-1β的表达。

Soluble uric acid increases NALP3 inflammasome and interleukin-1β expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway.

作者信息

Xiao Jing, Zhang Xiao-Li, Fu Chensheng, Han Rui, Chen Weijun, Lu Yijun, Ye Zhibin

机构信息

Department of Nephrology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China.

出版信息

Int J Mol Med. 2015 May;35(5):1347-54. doi: 10.3892/ijmm.2015.2148. Epub 2015 Mar 18.

DOI:10.3892/ijmm.2015.2148
PMID:25813103
Abstract

Urate crystals activate innate immunity through Toll like receptor 4 (TLR4) activation, leading to the formation of the NACHT, LRR and PYD domains-containing protein 3 [NALP3; also known as NOD-like receptor family, pyrin domain containing 3 (NALP3) and cryopyrin] inflammasome, caspase-1 activation and interleukin (IL)-1β expression in gout. However, whether elevated serum uric acid (UA) levels are associated with the development and progression of renal diseases without renal urate crystal deposition remains unknown. In the present study, human primary renal proximal tubule epithelial cells were incubated with soluble UA (100 µg/ml) with or without the TLR4 inhibitor, TAK242 (1 µM). The gene expression and protein synthesis of TLR4, NALP3, caspase-1, IL-1β and intercellular adhesion molecule-1 (ICAM-1) were detected by real-time PCR, ELISA, western blot analysis and fluorescence-activated cell sorting (FACS), respectively. Soluble UA significantly enhanced TLR4, NALP3, caspase-1, IL-1β and ICAM-1 expression in the human primary renal proximal tubule epithelial cells. The TLR4 inhibitor, TAK242 effectively blocked the soluble UA-induced upregulation of TLR4, NALP3, caspase-1, IL-1β and ICAM-1 expression in the human primary renal proximal tubule epithelial cells. Our findings indicate that soluble UA enhances NALP3 expression, caspase-1 activation, IL-1β and ICAM-1 production in renal proximal tubule epithelial cells in a TLR4-dependent manner, suggesting the activation of innate immunity in human primary renal proximal tubule epithelial cells by soluble UA.

摘要

尿酸盐晶体通过激活Toll样受体4(TLR4)来激活先天免疫,从而导致含NACHT、LRR和PYD结构域的蛋白3[NALP3;也称为NOD样受体家族含pyrin结构域3(NALP3)和冷吡啉]炎性小体的形成、胱天蛋白酶-1的激活以及痛风中白细胞介素(IL)-1β的表达。然而,血清尿酸(UA)水平升高是否与无肾尿酸盐晶体沉积的肾脏疾病的发生和发展相关仍不清楚。在本研究中,将人原代肾近端小管上皮细胞与可溶性UA(100μg/ml)一起孵育,同时添加或不添加TLR4抑制剂TAK242(1μM)。分别通过实时PCR、ELISA、蛋白质印迹分析和荧光激活细胞分选(FACS)检测TLR4、NALP3、胱天蛋白酶-1、IL-1β和细胞间黏附分子-1(ICAM-1)的基因表达和蛋白质合成。可溶性UA显著增强了人原代肾近端小管上皮细胞中TLR4、NALP3、胱天蛋白酶-1、IL-1β和ICAM-1的表达。TLR4抑制剂TAK242有效阻断了可溶性UA诱导的人原代肾近端小管上皮细胞中TLR4、NALP3、胱天蛋白酶-1、IL-1β和ICAM-1表达的上调。我们的研究结果表明,可溶性UA以TLR4依赖的方式增强肾近端小管上皮细胞中NALP3的表达、胱天蛋白酶-1的激活、IL-1β和ICAM-1的产生,提示可溶性UA激活人原代肾近端小管上皮细胞中的先天免疫。

相似文献

1
Soluble uric acid increases NALP3 inflammasome and interleukin-1β expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway.可溶性尿酸通过Toll样受体4介导的途径增加人原代肾近端小管上皮细胞中NALP3炎性小体和白细胞介素-1β的表达。
Int J Mol Med. 2015 May;35(5):1347-54. doi: 10.3892/ijmm.2015.2148. Epub 2015 Mar 18.
2
Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells.可溶性尿酸单钠而非其晶体可诱导肾系膜细胞中Toll样受体4依赖性免疫激活。
Mol Immunol. 2015 Aug;66(2):310-8. doi: 10.1016/j.molimm.2015.03.250. Epub 2015 Apr 21.
3
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.氟非尼酮通过抑制NALP3炎性小体和IL-1β/IL-1R1/MyD88/NF-κB信号通路的激活来减轻肺部炎症和纤维化。
J Cell Mol Med. 2016 Nov;20(11):2064-2077. doi: 10.1111/jcmm.12898. Epub 2016 Jun 16.
4
Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals.过氧化物酶体增殖物激活受体γ可防止尿酸单钠晶体刺激的HK-2肾小管上皮细胞中含NOD样受体家族、吡啉结构域的3炎性小体和白细胞介素1β的产生。
Mol Med Rep. 2015 Oct;12(4):6221-6. doi: 10.3892/mmr.2015.4145. Epub 2015 Jul 29.
5
Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.痛风先天免疫反应的遗传和表观遗传调控。
Immunol Invest. 2023 Apr;52(3):364-397. doi: 10.1080/08820139.2023.2168554. Epub 2023 Feb 6.
6
Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.高尿酸血症诱导的巨噬细胞NLRP3激活促进糖尿病肾病的进展。
Am J Physiol Renal Physiol. 2015 May 1;308(9):F993-F1003. doi: 10.1152/ajprenal.00637.2014. Epub 2015 Jan 28.
7
Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.芦荟下调脂多糖诱导的人巨噬细胞中炎症细胞因子的产生和 NLRP3 炎性体的表达。
Mol Immunol. 2013 Dec;56(4):471-9. doi: 10.1016/j.molimm.2013.05.005. Epub 2013 Aug 1.
8
TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia.TLR4 和 NALP3 炎性小体在尿毒症内皮功能障碍中的作用。
Eur J Clin Invest. 2015 Feb;45(2):160-9. doi: 10.1111/eci.12392. Epub 2015 Jan 7.
9
A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.尿酸和 Nalp3 炎性小体在抗磷脂抗体诱导人早孕绒毛滋养层细胞产生 IL-1β中的作用。
PLoS One. 2013 Jun 6;8(6):e65237. doi: 10.1371/journal.pone.0065237. Print 2013.
10
Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.敲低 TLR4 通过 NALP3/ASC/Caspase-1 信号通路减轻高糖诱导的足细胞损伤。
Biomed Pharmacother. 2018 Nov;107:1393-1401. doi: 10.1016/j.biopha.2018.08.134. Epub 2018 Aug 31.

引用本文的文献

1
Uric Acid and Preeclampsia: Pathophysiological Interactions and the Emerging Role of Inflammasome Activation.尿酸与子痫前期:病理生理相互作用及炎性小体激活的新作用
Antioxidants (Basel). 2025 Jul 29;14(8):928. doi: 10.3390/antiox14080928.
2
Exploring the relationship between circadian syndrome, serum uric acid levels, and hyperuricemia: evidence from NHANES 2005-2018.探索昼夜节律综合征、血清尿酸水平与高尿酸血症之间的关系:来自2005 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Sci Rep. 2025 Aug 7;15(1):28984. doi: 10.1038/s41598-025-14676-8.
3
Association of uric acid with all-cause mortality in acute coronary syndrome patients with T2DM.
2型糖尿病急性冠脉综合征患者尿酸与全因死亡率的关系
Atheroscler Plus. 2025 Jun 8;61:12-17. doi: 10.1016/j.athplu.2025.06.001. eCollection 2025 Sep.
4
New Insights into Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease.缺血性心脏病病理生理学中尿酸代谢的新见解。
Eur Cardiol. 2025 Jun 12;20:e18. doi: 10.15420/ecr.2024.30. eCollection 2025.
5
Cathepsin B-dependent glycolysis contributes to reduced renal uric acid excretion in hyperuricemia.组织蛋白酶B依赖性糖酵解导致高尿酸血症患者肾脏尿酸排泄减少。
Commun Biol. 2025 Jun 2;8(1):845. doi: 10.1038/s42003-025-08303-5.
6
JAK2/STAT3/HMGCS2 signaling aggravates mitochondrial dysfunction and oxidative stress in hyperuricemia-induced cardiac dysfunction.JAK2/STAT3/HMGCS2信号通路加重高尿酸血症诱导的心脏功能障碍中的线粒体功能障碍和氧化应激。
Mol Med. 2025 May 13;31(1):184. doi: 10.1186/s10020-025-01246-x.
7
Serum uric acid level as a prognostic biomarker in critically ill patients with sepsis-associated acute kidney injury: A retrospective single-center study.血清尿酸水平作为脓毒症相关急性肾损伤重症患者的预后生物标志物:一项回顾性单中心研究。
PLoS One. 2025 May 7;20(5):e0321576. doi: 10.1371/journal.pone.0321576. eCollection 2025.
8
Isolation and Characterization of Highly Active Uricase from spp. Strain UR1.来自某菌株UR1的高活性尿酸酶的分离与鉴定
Pol J Microbiol. 2025 Mar 26;74(1):106-129. doi: 10.33073/pjm-2025-009. eCollection 2025 Mar 1.
9
Impact of Chronic Kidney Disease and Gout on End-Stage Renal Disease in Type 2 Diabetes: Population-Based Cohort Study.慢性肾脏病和痛风对 2 型糖尿病终末期肾病的影响:基于人群的队列研究。
Endocrinol Metab (Seoul). 2024 Oct;39(5):748-757. doi: 10.3803/EnM.2024.2020. Epub 2024 Aug 30.
10
DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway.傣通消通过TLR4/MyD88/NF-κB途径抑制炎症反应,从而改善痛风性肾病。
Front Pharmacol. 2024 Aug 7;15:1447241. doi: 10.3389/fphar.2024.1447241. eCollection 2024.